Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...
Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...
About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...
Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...
In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...
Neumora Therapeutics ( NMRA) shares crashed 80% to an all-time low Thursday when the biopharmaceutical firm announced that a ...
The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...
In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...
After six weeks, both the treatment group and the placebo group experienced an average 12.5-point reduction on the Montgomery-Åsberg Depression Rating Scale (MADRS). The drug also fell short in i ...
Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...
How Can Low-Dose Ketamine, a 'Lifesaving' Drug for Major Depression, Alleviate Symptoms Within Hours? Nov. 18, 2024 — Neuroscientists have identified the binding site of low-dose ketamine ...
Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback